This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sanofi. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Helene Bonnevaux: Innovator in Cancer Treatment
Introduction
Helene Bonnevaux is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic antibodies.
Latest Patents
Helene Bonnevaux holds a patent for "Anti-GPRC5D antibodies and compositions." This patent provides antigen-binding proteins that specifically bind to GPRC5D, along with respective antibodies in enhanced ADCC formats. The methods described in her patent are aimed at treating cancers, including multiple myeloma.
Career Highlights
Helene is currently associated with Sanofi, a leading global healthcare company. Her work focuses on developing advanced therapeutic solutions that can improve patient outcomes in oncology.
Collaborations
Throughout her career, Helene has collaborated with notable colleagues, including Elisabeth Remy and Klervi Desrumeaux. These partnerships have fostered a collaborative environment that enhances innovation and research in cancer therapies.
Conclusion
Helene Bonnevaux is a trailblazer in the field of cancer treatment, with her patent on Anti-GPRC5D antibodies showcasing her commitment to advancing medical science. Her contributions continue to impact the lives of patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile